ReportsWorldwide.com announces distribution of iGATE Research Reports

As the leading distributor of market intelligence, ReportsWorldwide.com is pleased to announce a business partnership with iGATE Research which allows for the marketing and distribution of research reports published by iGATE Research through the ReportsWorldwide.com website.

“Our ability to join hands with exceptional research publishers such as iGATE Research allows us to not only broaden the scope of research available in the Lifesciences, Travel & Tourism and Transportation & Logistics industry, it also allows business professionals throughout the world easier access to investment grade reports of great value that they may have previously been unaware of in this field,” stated Abigail Crasto, Senior Vice President, Partner Relations at ReportsWorldwide.com.

Commenting on the partnership agreement, Rajiv Ranjan, (Director, iGATE Research), said: “We are more than happy that ReportsWorldwide.com has become our distribution partner. We offer high-quality Research Solutions to clients across multiple industries including Healthcare, Travel and Tourism, Retail & IT among others. Partnering with ReportsWorldwide.com is an exceptional opportunity for us as our product line is an excellent fit for this resource avenue. We believe that teaming up with ReportsWorldwide.com will increase exposure of our reports and have a positive impact on our business as our reports make it into the hands of a wider global audience”.

To see all reports from IGATE Research, visit: http://bit.ly/2dpFbh7

Some of iGATE Research’s recent publications include:

1. Neuromodulation Market (by Technology, Applications Segment, Region and Company) and Forecast to 2021 - Global Analysis

The global neuromodulation market is poised to cross US$ 5 Billion mark by 2021. In terms of technology, Spinal cord stimulation (SCS) is the largest segment of the market followed by Deep brain stimulation (DBS) at the second spot and Sacral nerve stimulation (SNS) at the third spot in 2015. In terms of applications, Chronic pain is the leading application segment of the neuromodulation market. The urinary and fecal incontinence market is the second largest application segment of the neuromodulation market. Refractory epilepsy holds third highest share of the neuromodulation market in 2015 being followed by Parkinsons disease.

Geographically, North America is at the forefront of neuromodulation innovation, accounting for lion’s share of the global neuromodulation market in 2015. Europe is likely to remain at second position throughout the forecasting period. Medtronic has been the dominant market player in the global neuromodulation market. However, it is facing increased competition from other players operating in the neuromodulation market. Boston Scientific is the second leading player for neuromodulation market being followed by St. Jude Medical.

2. Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis

The global biosimilars market is predicted to cross US$ 25 Billion mark by 2020. With the continuous increasing demand for biologics, manufacturers are looking for novel strategies that will help them attain maximum returns on investment.

Key Highlights of the Report:

The erythropoietin (EPO) captures maximum share of the global biosmilars market.
The Granulocyte- Colony Stimulating Factor (G-CSF) market is expected to cross US$ 6 Billion mark by 2021.
The monoclonal antibody is expected to show the highest growth rate during the period 2016 - 2021.
Among various application segments of biosimilar market, blood disorders and oncology together accounted for over 55% share of the global biosimilars market in 2015.
The market for biosimilars in the U.S. has gained momentum after the launch of Novartis Zarxio in September 2015.
India is seen as a key player in the biosimilar space with an exceptionally high number of approvals granted in the last decade compared to the global average.

3. Proton Therapy Market Outlook - Global Analysis

The unprecedented demand of proton therapy for the treatment of cancer has set the stage for the market to move ahead at a rapid pace. The main advantage of proton therapy is that while destroying the target malignant cells, it causes minimal damage to the surrounding cells.

The number of proton therapy centers is increasing globally. Still, industry experts believe that players will miss out on a majority of cancer patients who can benefit with proton therapy, overlooking a huge multi-Billion-dollar potential market. Globally, the numbers of patients treated with Proton Therapy is very low whereas; the potential candidates for proton therapy are in Millions. IBA dominates the proton therapy market globally. However other players like Varian, Mitsubishi, Mevion, Hitachi etc. have also started to make their presence felt in the market. The number of proton therapy centers worldwide is anticipated to increase year on year, which in turn, will result in more clinical research, better clinician understanding and greater patient awareness of its benefits-which will help drive the further growth.

ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends. Moreover, ReportsWorldwide's Research Associates have in-depth knowledge of the reports and services on offer and are ready to provide assistance.

Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston, MA 02110
US
Phone +1 (617) 398-4994
Fax +1 (617) 398-4995
abigail@reportsworldwide.com

This release was published on openPR.